92 related articles for article (PubMed ID: 36197776)
1. A Snapshot of the Landscape of Endocervical Adenocarcinoma in Kenya: What Has HPV Got to Do with It?
Wawire J; Njenga P; Moloo Z; Sung CJ; Quddus MR
Ann Clin Lab Sci; 2022 Jul; 52(4):621-627. PubMed ID: 36197776
[TBL] [Abstract][Full Text] [Related]
2. International Endocervical Adenocarcinoma Criteria and Classification (IECC): A New Pathogenetic Classification for Invasive Adenocarcinomas of the Endocervix.
Stolnicu S; Barsan I; Hoang L; Patel P; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Pike MC; Oliva E; Park KJ; Soslow RA
Am J Surg Pathol; 2018 Feb; 42(2):214-226. PubMed ID: 29135516
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in invasive adenocarcinoma of the cervix.
Stolnicu S; Hoang L; Soslow RA
Virchows Arch; 2019 Nov; 475(5):537-549. PubMed ID: 31209635
[TBL] [Abstract][Full Text] [Related]
4. Cytology, High-Risk Human Papillomavirus Testing and Serum CA19-9 in a Large Cohort of Patients with Invasive Cervical Adenocarcinomas: Correlation with a New Pathogenetic Classification.
Shi H; Ma Y; Shao Y; Zhang Y; Lu B
Asian Pac J Cancer Prev; 2022 Aug; 23(8):2599-2605. PubMed ID: 36037112
[TBL] [Abstract][Full Text] [Related]
5. The distribution of hrHPV genotypes among cervical cancer cases diagnosed across Ghana: a cross-sectional study.
Akakpo PK; Imbeah EG; Ulzen-Appiah K; Darkwa-Abrahams A; Adjei E; Amo-Antwi K; Amo EO; Der EM; Wiredu EK
BMC Infect Dis; 2024 Mar; 24(1):356. PubMed ID: 38539128
[TBL] [Abstract][Full Text] [Related]
6. [Endocervical adenocarcinomas classified by International Endocervical Adenocarcinoma Criteria and Classification: a clinicopathological and prognostic analysis of 286 cases].
Lyu BJ; Shi HY; Shao Y; Liu Q; Lyu WG
Zhonghua Bing Li Xue Za Zhi; 2021 Sep; 50(9):1014-1019. PubMed ID: 34496491
[No Abstract] [Full Text] [Related]
7. Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory.
Zheng B; Li Z; Griffith CC; Yan S; Chen C; Ding X; Liang X; Yang H; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):428-34. PubMed ID: 25954852
[TBL] [Abstract][Full Text] [Related]
8. Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus.
Park KJ; Kiyokawa T; Soslow RA; Lamb CA; Oliva E; Zivanovic O; Juretzka MM; Pirog EC
Am J Surg Pathol; 2011 May; 35(5):633-46. PubMed ID: 21490443
[TBL] [Abstract][Full Text] [Related]
9. A retrospective study on incidence, diagnosis, and clinical outcome of gastric-type endocervical adenocarcinoma in a single institution.
Radomska A; Lee D; Neufeld H; Korte N; Torlakovic E; Agrawal A; Chibbar R
Diagn Pathol; 2021 Jul; 16(1):68. PubMed ID: 34332600
[TBL] [Abstract][Full Text] [Related]
10. Endocervical Adenocarcinoma With Morphologic Features of Both Usual and Gastric Types: Clinicopathologic and Immunohistochemical Analyses and High-risk HPV Detection by In Situ Hybridization.
Wada T; Ohishi Y; Kaku T; Aman M; Imamura H; Yasutake N; Sonoda K; Kato K; Oda Y
Am J Surg Pathol; 2017 May; 41(5):696-705. PubMed ID: 28296678
[TBL] [Abstract][Full Text] [Related]
11. International Endocervical Adenocarcinoma Criteria and Classification: Validation and Interobserver Reproducibility.
Hodgson A; Park KJ; Djordjevic B; Howitt BE; Nucci MR; Oliva E; Stolnicu S; Xu B; Soslow RA; Parra-Herran C
Am J Surg Pathol; 2019 Jan; 43(1):75-83. PubMed ID: 29877920
[TBL] [Abstract][Full Text] [Related]
12. International Endocervical Adenocarcinoma Criteria and Classification (IECC): correlation with adverse clinicopathological features and patient outcome.
Hodgson A; Olkhov-Mitsel E; Howitt BE; Nucci MR; Parra-Herran C
J Clin Pathol; 2019 May; 72(5):347-353. PubMed ID: 30679193
[TBL] [Abstract][Full Text] [Related]
13. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
[TBL] [Abstract][Full Text] [Related]
14. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
[TBL] [Abstract][Full Text] [Related]
15. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix.
Zielinski GD; Snijders PJ; Rozendaal L; Daalmeijer NF; Risse EK; Voorhorst FJ; Jiwa NM; van der Linden HC; de Schipper FA; Runsink AP; Meijer CJ
J Pathol; 2003 Dec; 201(4):535-43. PubMed ID: 14648656
[TBL] [Abstract][Full Text] [Related]
16. Reproducibility of Morphologic Parameters of the International Endocervical Adenocarcinoma Criteria and Classification System and Correlation With Clinicopathologic Parameters: A Multi-Institutional Study.
Bulutay P; Haberal N; Özen Ö; Erdem Ö; Zeren EH; Kulac İ; Taskiran Ç; Vatansever D; Ayhan A; Kapucuoğlu N
Int J Gynecol Pathol; 2022 Sep; 41(5):447-458. PubMed ID: 34856570
[TBL] [Abstract][Full Text] [Related]
17. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
[TBL] [Abstract][Full Text] [Related]
18. Genotype distribution of cervical HPV among Caribbean women in a population-based study in Martinique: The DEPIPAPUFR study.
Najioullah F; Dorival MJ; Joachim C; Dispagne C; Macni J; Abel S; Sulpicy C; Charpentier-Baltide H; Sainte-Rose D; Salomon-Frechou B; Dieye M; Véronique-Baudin J; Pré M; Marquet M; Wan-Ajouhu G; Janky E; Riethmuller D; Cesaire R;
PLoS One; 2021; 16(10):e0257915. PubMed ID: 34618835
[TBL] [Abstract][Full Text] [Related]
19. The value of HPV DNA typing in the distinction between adenocarcinoma of endocervical and endometrial origin.
Plunkett M; Brestovac B; Thompson J; Sterrett G; Filion P; Smith D; Frost F
Pathology; 2003 Oct; 35(5):397-401. PubMed ID: 14555383
[TBL] [Abstract][Full Text] [Related]
20. Clinical Outcomes of HPV-associated and Unassociated Endocervical Adenocarcinomas Categorized by the International Endocervical Adenocarcinoma Criteria and Classification (IECC).
Stolnicu S; Hoang L; Chiu D; Hanko-Bauer O; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Oliva E; Park KJ; Abu-Rustum NR; Soslow RA
Am J Surg Pathol; 2019 Apr; 43(4):466-474. PubMed ID: 30720532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]